首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1092138篇
  免费   74777篇
  国内免费   1392篇
耳鼻咽喉   15445篇
儿科学   35110篇
妇产科学   28932篇
基础医学   155751篇
口腔科学   29846篇
临床医学   97313篇
内科学   207041篇
皮肤病学   24770篇
神经病学   83132篇
特种医学   43775篇
外国民族医学   201篇
外科学   166144篇
综合类   22053篇
现状与发展   1篇
一般理论   283篇
预防医学   76277篇
眼科学   24882篇
药学   87341篇
  7篇
中国医学   2819篇
肿瘤学   67184篇
  2021年   8318篇
  2019年   8459篇
  2018年   12132篇
  2017年   9445篇
  2016年   10628篇
  2015年   11833篇
  2014年   16080篇
  2013年   23481篇
  2012年   32027篇
  2011年   33711篇
  2010年   19717篇
  2009年   18445篇
  2008年   30927篇
  2007年   33081篇
  2006年   33578篇
  2005年   31795篇
  2004年   30495篇
  2003年   29144篇
  2002年   28071篇
  2001年   60319篇
  2000年   61824篇
  1999年   51177篇
  1998年   12575篇
  1997年   11112篇
  1996年   11115篇
  1995年   10404篇
  1994年   9422篇
  1993年   8934篇
  1992年   38001篇
  1991年   36449篇
  1990年   35930篇
  1989年   34468篇
  1988年   31051篇
  1987年   30148篇
  1986年   28427篇
  1985年   26585篇
  1984年   19314篇
  1983年   16216篇
  1982年   8905篇
  1979年   17154篇
  1978年   11480篇
  1977年   10281篇
  1976年   8895篇
  1975年   10132篇
  1974年   11702篇
  1973年   11329篇
  1972年   10794篇
  1971年   10155篇
  1970年   9317篇
  1969年   8983篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional...  相似文献   
3.
Molnár  B.  Aroca  S.  Dobos  A.  Orbán  K.  Szabó  J.  Windisch  P.  Stähli  A.  Sculean  A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with...  相似文献   
4.
5.
6.
7.
8.
Inflammatory bowel disease (IBD) is a chronic disease that requires chronic treatment throughout the evolution of the disease, with a complex physiopathology that entails great challenges for the development of new and specific treatments for ulcerative colitis and Crohn´s disease. The anti-tumor necrosis factor alpha therapy has impacted the clinical course of IBD in those patients who do not respond to conventional treatment, so there is a need to develop new therapies and markers of treatment response. Various pathways involved in the development of the disease are known and the new therapies have focused on blocking the inflammatory process at the gastrointestinal level by oral, intravenous, subcutaneous, and topical route. All these new therapies can lead to more personalized treatments with higher success rates and fewer relapses. These treatments have not only focused on clinical remission, but also on achieving macroscopic changes at the endoscopic level and microscopic changes by achieving mucosal healing. These treatments are mainly based on modifying signaling pathways, by blocking receptors or ligands, reducing cell migration and maintaining the integrity of the epithelial barrier. Therefore, this review presents the efficacy and safety of the new treatments that are currently under study and the advances that have been made in this area in recent years.  相似文献   
9.
10.
Comprehensive evidence regarding the treatment of non-anaemic iron deficiency in patients undergoing valvular heart surgery is lacking. This study aimed to investigate the association between non-anaemic iron deficiency and postoperative outcomes in these patients. We retrospectively analysed 321 patients of which 180 (56%) had iron deficiency (defined as serum ferritin < 100 ng.ml-1 or < 300 ng.ml-1 with transferrin saturation < 20%). While the iron-deficient group had lower pre-operative haemoglobin levels than the non-iron deficient group (median (IQR [range]) 134 (127–141 [120–172]) g.l-1, 143 (133–150 [120–179]) g.l-1, p = 0.001), there was no between-group difference in allogeneic red blood cell transfusion. Median (IQR [range]) days alive and out of hospital at postoperative day 90 was 1 day shorter in the iron-deficient group (80 (77–82 [9–85]) days vs. 81 (79–83 [0–85]) days, p = 0.026). In multivariable analysis, only cardiopulmonary bypass duration (p = 0.032) and intra-operative allogeneic red blood cell transfusion (p = 0.011) were significantly associated with reduced days alive and out of hospital at postoperative day 90. Iron deficiency did not exert any adverse influence on secondary outcomes except length of hospital stay. Our findings indicate that non-anaemic iron deficiency alone is not associated with adverse effects in patients undergoing valvular heart surgery when it does not translate into an increased risk of allogeneic transfusion.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号